Medicine guide

LOQTORZI

As listed in the register: LOQTORZI 240 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

240 mg · concentrado para solución para perfusión

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Toripalimab
Made by
Topalliance Biosciences Europe Limited

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01FF13

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byTopalliance Biosciences Europe Limited
Active substanceToripalimab
Used inCancer treatments and immune-system medicines
Strength240 mg
Formconcentrado para solución para perfusión
ClassificationL01FF13 · Cancer treatments and immune-system medicines
Routevía intravenosa
MarketedYes, according to the register
SupplyThe regulator reports a supply problem for this product.
Additional monitoring ▼Yes — under additional monitoring (black triangle). Report suspected side effects.
DrivingThe regulator flags that this medicine can affect the ability to drive.
Name in the registerLOQTORZI 240 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Nº Registro1241853001

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.